Enabling a Healthier World

About Lonza

At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Our community of 15,000 skilled employees work across a global network of more than 30 sites to deliver for our customers across the pharma, biotech and nutrition markets. By combining technological insight with world-class manufacturing, scientific expertise and process excellence, we help our customers to deliver new and innovative medicines that help treat a wide range of diseases.

Our Offering

We help customers develop, manufacture, and innovate their small molecule medicines through our commitment to science, technology and delivery. We provide integrated drug substance and drug product services through our global site network with a strong track record of being present throughout the product lifecycle.

In our extensive contract development and manufacturing services portfolio we use advanced technologies to quickly and efficiently deliver products such as monoclonal antibodies, complex proteins and recombinant proteins.

Our Cell & Gene offering spans across development and manufacturing services, products, solutions, testing and automation platforms including the Cocoon®, as well as tools and technologies to develop, de-risk and industrialize therapies from basic research to commercialization.

Our CHI business offers innovative capsules, dosage form solutions and health ingredients for pharmaceutical and nutraceutical companies.

You can visit the new website of our former Specialty Ingredients business (LSI) by clicking here

Our locations

lonza employee in lab environment

Join our team

Lonza’s stock

LONZA GROUP AG-REG
(LONN.SW: SIX Swiss Ex)
Last price:

CHF 748.40

Change today:

4.40 (%-0.58)

Investor Relations